Deerfield Management Co. has made bets on more than 100 biotech firms, including many in the Philadelphia area. The
A new biotech, EQRx, raised $200 million in series A funding to develop patent-protected drugs that will cost less ...
China-based I-Mab (NASDAQ: IMAB), a clinical stage biopharmaceutical company committed to the discovery, ...
Investor Watch Series
No results found.